A double-blind randomized controlled trial of the effects of eicosapentaenoic acid supplementation on muscle inflammation and physical function in patients undergoing colorectal cancer resection

被引:18
|
作者
Hossain, Tanvir [1 ,2 ]
Phillips, Bethan E. [3 ,4 ]
Doleman, Brett [1 ,2 ]
Lund, Jonathan N. [1 ,2 ,3 ,4 ]
Williams, John P. [1 ,2 ,3 ,4 ]
机构
[1] Royal Derby Hosp, Dept Surg, Derby DE22 3DT, England
[2] Royal Derby Hosp, Dept Anaesthet, Derby DE22 3DT, England
[3] Univ Nottingham, Royal Derby Hosp Ctr, Clin Metab & Mol Physiol Res Grp, Derby DE22 3DT, England
[4] Univ Nottingham, Royal Derby Hosp Ctr, MRC, Arthrit Res UK Ctr Musculoskeletal Ageing Res, Derby DE22 3DT, England
基金
英国医学研究理事会;
关键词
Cancer; Colorectal; Muscle; Eicosapentaenoic acid; Surgery; Inflammation; FISH-OIL; SURGICAL RESECTION; CLINICAL-TRIAL; PARENTERAL-NUTRITION; SURGERY; PROTEIN; WEIGHT; OMEGA-3-FATTY-ACIDS; ACTIVATION; EXPRESSION;
D O I
10.1016/j.clnu.2019.09.009
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Resection of colorectal cancer (CRC) initiates inflammation, mediated at least partly by NF kappa B (nuclear factor kappa-light-chain-enhancer of activated B-cells), leading to muscle catabolism and reduced physical performance. Eicosapentaenoic acid (EPA) has been shown to modulate NF kappa B, but evidence for its benefit around the time of surgery is limited. Objective: To assess the effect of EPA supplementation on muscle inflammation and physical function around the time of major surgery. Design: In a double-blind randomized control trial, 61 patients (age: 68.3 +/- 0.95 y; 42 male) scheduled for CRC resection, received 3 g per day of EPA (n = 32) or placebo (n = 29) for 5-days before and 21-days after operation. Lean muscle mass (LMM) (via dual energy X-ray absorptiometry (DXA)), anaerobic threshold (AT) (via cardiopulmonary exercise testing (CPET)) and hand-grip strength (HG) were assessed before and 4-weeks after surgery, with muscle biopsies (m. vastus lateralis) obtained for the assessment of NF-kappa B protein expression. Results: There were no differences in muscle NF kappa B between EPA and placebo groups (mean difference (MD) -0.002; 95% confidence interval (CI) -0.19 to 0.19); p = 0.98). There was no difference in LMM (MD 704.77 g; 95% CI -1045.6 g-2455.13 g; p = 0.42) or AT (MD 1.11 mls/kg/min; 95% CI -0.52 mls/kg/min to 2.74 mls/kg/min; p = 0.18) between the groups. Similarly, there was no difference between the groups in HG at follow up (MD 0.1; 95% CI -1.88 to 2.08; p = 0.81). Results were similar when missing data was imputed. Conclusion: EPA supplementation confers no benefit in terms of inflammatory status, as judged by NF kappa B, or preservation of LMM, aerobic capacity or physical function following major colorectal surgery. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:2055 / 2061
页数:7
相关论文
共 50 条
  • [1] The effects of synbiotic supplementation on thyroid function and inflammation in hypothyroid patients: A randomized, double-blind, placebo-controlled trial
    Talebi, Sepide
    Karimifar, Mozhgan
    Heidari, Zahra
    Mohammadi, Hamed
    Askari, Gholamreza
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 48
  • [2] Effects of propolis on inflammation markers in patients undergoing hemodialysis: A randomized, double-blind controlled clinical trial
    Chermut, Tuany Ramos
    Fonseca, Larissa
    Figueiredo, Nathalia
    Leal, Viviane de Oliveira
    Borges, Natalia Alvarenga
    Cardozo, Ludmila F. M. F.
    Leite, Paulo Emilio Correa
    Alvarenga, Livia
    Regis, Bruna
    Delgado, Alvimar
    Berretta, Andresa A.
    Ribeiro-Alves, Marcelo
    Mafra, Denise
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2023, 51
  • [3] Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
    Higurashi, Takuma
    Hosono, Kunihiro
    Endo, Hiroki
    Takahashi, Hirokazu
    Iida, Hiroshi
    Uchiyama, Takashi
    Ezuka, Akiko
    Uchiyama, Shiori
    Yamada, Eiji
    Ohkubo, Hidenori
    Sakai, Eiji
    Maeda, Shin
    Morita, Satoshi
    Natsumeda, Yutaka
    Nagase, Hajime
    Nakajima, Atsushi
    BMC CANCER, 2012, 12
  • [4] Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
    Takuma Higurashi
    Kunihiro Hosono
    Hiroki Endo
    Hirokazu Takahashi
    Hiroshi Iida
    Takashi Uchiyama
    Akiko Ezuka
    Shiori Uchiyama
    Eiji Yamada
    Hidenori Ohkubo
    Eiji Sakai
    Shin Maeda
    Satoshi Morita
    Yutaka Natsumeda
    Hajime Nagase
    Atsushi Nakajima
    BMC Cancer, 12
  • [5] Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
    Dobs, Adrian S.
    Boccia, Ralph V.
    Croot, Christopher C.
    Gabrail, Nashat Y.
    Dalton, James T.
    Hancock, Michael L.
    Johnston, Mary A.
    Steiner, Mitchell S.
    LANCET ONCOLOGY, 2013, 14 (04): : 335 - 345
  • [6] Effect of darbepoetin alfa on physical function in patients undergoing surgery for colorectal cancer - A randomized, double-blind, placebo-controlled study
    Norager, C. B.
    Jensen, M. B.
    Madsen, M. R.
    Qvist, N.
    Laurberg, S.
    ONCOLOGY, 2006, 71 (3-4) : 212 - 220
  • [7] Effects of Curcumin Supplementation on Clinical Features and Inflammation, in Migraine Patients: A Double-Blind Controlled, Placebo Randomized Clinical Trial
    Rezaie, Sheyda
    Askari, Gholamreza
    Khorvash, Fariborz
    Tarrahi, Mohammad Javad
    Amani, Reza
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2021, 12 (01)
  • [8] Effects of creatine supplementation on nutritional status, muscle function and quality of life in patients with colorectal cancer -: A double blind randomised controlled trial
    Norman, Kristina
    Stuebler, Dominik
    Baier, Peter
    Schuetz, Tanja
    Ocran, Kenneth
    Holm, Eggert
    Lochs, Herbert
    Pirlich, Matthias
    CLINICAL NUTRITION, 2006, 25 (04) : 596 - 605
  • [9] Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia
    Fearon, Kenneth C. H.
    Barber, Matthew D.
    Moses, Alastair G.
    Ahmedzai, Sam H.
    Taylor, Gillian S.
    Tisdale, Michael J.
    Murray, Gordon D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3401 - 3407
  • [10] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30